New Model Transforms Multiple Myeloma Risk Prediction
A team of researchers has developed a powerful new tool that could transform how doctors treat multiple myeloma, a complex and often unpredictable blood cancer.
Back to Previous Page
ISB News
Filter
-
- All Categories
- Autoimmune Diseases
- Baliga Lab
- Brain Health
- Cancer
- Chronic Illness
- Climate Change
- Courses and Symposia
- COVID and Long COVID
- Early Detection and Diagnosis
- Education
- Environment
- Events
- Gibbons Lab
- Hadlock Lab
- Hands-on Learning
- Health
- Health Data Science Lab
- Health Equity
- Healthspan and Longevity
- Heath Lab
- Hood Lab
- Huang Lab
- Infectious Disease
- Internships
- ISB-Town Hall
- Kane Lab
- Kuchina Lab
- Logan Center for Education
- Lyme Disease
- Malaria
- Maternal and Infant Health
- Microbiome
- Moritz Lab
- Neurological Disorders
- Optimizing Outcomes
- People
- Philanthropy
- Precision Treatments
- Press Release
- Proteins and Disease
- Ranish Lab
- Real-world Science
- Research Roundtable
- Subramanian Lab
- Sustainability and Remediation
- Systemic Change
- Systems Education Experiences
- Thorsson-Shmulevich Lab
- Treatments and Resistance
- Tuberculosis
- Understanding Tumors
- Venkatesh Lab
- Wei Lab
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
2024-25 School Year ISB Education Highlights
In the March installment of the 2024-25 academic year roundup, we highlight how ISB educators have been active in the local community, and more.
ISB’s Sui Huang Challenges the Genetic Paradigm of Cancer in New Essay
ISB Professor Sui Huang challenges the prevailing view of cancer as purely genetic in a new essay published in PLOS Biology. Huang and colleagues argue that many cancers lack identifiable driver mutations, suggesting non-genetic factors and disrupted gene regulatory networks may play crucial roles in cancer development.
Melanoma Starts Evading Treatment Within Hours – Here’s How to Stop It
ISB researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.
Scientists Decode Diet From Stool DNA – No Questions Asked
ISB's Gibbons Lab developed a breakthrough method that analyzes food-derived DNA in fecal metagenomes, allowing for data-driven diet tracking without the need for burdensome questionnaires.
Carole Ellison’s Bold Bet on Science and the Researchers of Tomorrow
Carole Ellison has supported ISB’s research and STEM programs for over a decade. She established the K. Carole Ellison Fellowship in Bioinformatics, funding groundbreaking research that has enabled young scientists to make critical discoveries.